Single Centre Prospective Study to Obtain Data to Train an Algorithm for Prediction of Outcome in Transcatheter Aortic Valve Implantation (TAVI)

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of this study is to learn if the Computed Tomography scan (CT scan) and heart echo scan TransThoracic Echo scan (TTE or heart echo scan) taken before a Transcatheter Aortic Valve Implantation (TAVI) procedure can be used to predict how the new TAVI valve will perform in the future. To do this the investigators need the usual CT scan before and a new CT scan after the TAVI valve has been put in. At present a CT scan after TAVI procedure is not routinely done. Male and female patients with severe Aortic Stenosis (AS) will be asked to take part. The data from the scans along with routine measures that are taken will be used to assess if there has been any deterioration in the valve at six months. The scan data collected will be used in a computer programme. This programme will be trained to predict TAVI valve performance. The main purpose of this study is to collect the CT scan data before and after the TAVI procedure. The study aims to answer: • Can the investigators obtain additional CT imaging data and other data before and after TAVI to enable the prediction of valve performance? Participants will be asked if they would have another CT scan 6 months after their TAVI procedure, during their routine follow up.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• ≥ 18 years of age

• Symptomatic, degenerative, tricuspid, severe aortic stenosis

• TTE derived aortic valve area (AVA) of ≤ 1.0 cm2 (or indexed effective orifice area (EOAi) ≤ 0.6 cm2 /m2)

• TTE derived AV mean gradient ≥ 40 mmHg or peak jet velocity ≥ 4.0 m/s or Doppler Velocity Index (DVI) ≤ 0.25

• CT TAVI deemed of good quality (as per standard operating procedure) within past 6 months

• TTE of good quality within past 6 months as defined by:

‣ Doppler signal across the aortic valve and LVOT is a clear and artifact-free waveform

⁃ Correct alignment to the blood flow direction to ensure accurate velocity measurements

⁃ Following measurements available

⁃ Continuous-wave Doppler (CW) across the aortic valve

⁃ AV Vmax, AV Vmean, AV peak gradient (MaxPG), AV mean gradient (meanPG), AV Velocity-Time integral (VTI), heart rate (HR);

⁃ Pulse-wave Doppler (PW) across the LVOT

⁃ LVOT Vmax, LVOT Vmean, LVOT MaxPG, LVOT meanPG, LVOT VTI;

⁃ 2D LVOT diameter in plax view.

• In sinus rhythm at time of any TTE or CT scans

• Undergone a technically successful elective TAVI as defined by the operator using a Edwards Sapien 3 Ultra (20, 23, 26 or 29 mm):

‣ Position and height as planned

⁃ Trivial aortic regurgitation

⁃ No vascular or other complications prolonging discharge

Locations
Other Locations
United Kingdom
St Bartholomew's Hospital
RECRUITING
London
Contact Information
Primary
R&D Governance Administrator
research.governance@qmul.ac.uk
+44 (0)20 7882 6826
Time Frame
Start Date: 2024-07-09
Estimated Completion Date: 2026-09-12
Participants
Target number of participants: 40
Treatments
Experimental: Computerised Tomography (CT) Intervention
Transpercutaneous Aortic Valve Implantation (TAVI) planning CT (adapted) of the heart and aortic arch at 6 months post TAVI
Sponsors
Collaborators: Queen Mary University of London
Leads: Barts & The London NHS Trust

This content was sourced from clinicaltrials.gov

Similar Clinical Trials